{Stature QTL 1} (2), STQTL1
Optic atrophy 4 (2), OPA4
Argininemia, ARG1
{Inflammatory bowel disease 11} (2), IBD11
Argininosuccinic aciduria, ASL
Ehlers-Danlos syndrome, type VIIB, COL1A2
[Bone mineral density QTL 5] (2), BMND5
Insulin-like growth factor I, resistance to, IGF1R
Myopia-3 (2), MYP3
Gustavson syndrome (2), GUST
Myotonia congenita, dominant, CLCN1
Galactokinase deficiency with cataracts, GALK1
Norum disease, LCAT
{Psoriasis susceptibility 11} (2), PSORS11
Parathyroid adenoma, MEN1
[Thyroid-stimulating hormone level QTL 1] (2), TSHQTL1
{Migraine, with or without aura, susceptibility to, MGR12
{Stature QTL 2} (2), STQTL2
Acropectoral syndrome (2), ACRPS
Erythrocytosis, familial, 2, VHL
Cervical carcinoma (2), ST3
Rhabdomyolysis, CYP2C8
{Panic disorder, susceptibility to}, COMT
Progressive familial heart block, PFHB2
Rickets, vitamin D-resistant, type IIA, VDR
Developmental dysplasia of the hip 1 (2), DDH1
Holoprosencephaly-1 (2), HPE1
Corpus callosum, agenesis of, with mental retardation, ocular coloboma and micrognathia, IGBP1
Myopia 9 (2), MYP9
FG syndrome 5 (2), FGS5
Cardiomyopathy, dilated, 1DD, RBM20
46XX sex reversal 3 (4), SRXX3
{Hypertension, essential, susceptibility to, 3}, HYT3
Severe combined immunodeficiency due to ADA deficiency, ADA
Glaucoma, primary open angle, juvenile-onset, JOAG2
Harderoporphyria, CPOX
Mean platelet volume QTL5 (2), MPVQTL5
{Seasonal affective disorder, susceptibility to}, HTR2A
Bleeding disorder, BDET
Carpenter syndrome, RAB23
Hemolytic anemia due to glutathione reductase deficiency (1), GSR
Deafness, autosomal dominant 5, DFNA5
Thyroxine-binding globulin deficiency (3), TBG
{Inflammatory bowel disease 26} (2), IBD26
N-acetylglutamate synthase deficiency, NAGS
Carotid intimal medial thickness (2), CIMT
Hashimoto thyroiditis (2), HT
{T-cell acute lymphoblastic leukemia} (3), MYB
Hypoparathyroidism, autosomal recessive, PTH
{Strabismus, susceptibility to, STBMS1
{Otosclerosis 4} (2), OTSC4
Amyloidosis, Finnish type, GSN
{Stature QTL 13} (2), STQTL13
Sandhoff disease, infantile, juvenile, and adult forms, HEXB
Optic atrophy 2, OPA2
Apolipoprotein A-II deficiency (3), APOA2
Epidermolysis bullosa of hands and feet, ITGB4
Small cell cancer of the lung, somatic, RB1
Bornholm eye disease (2), BED
Metaphyseal chondrodysplasia, Schmid type, COL10A1
[Longevity 1] (2), LGV1
Rippling muscle disease-1 (2), RMD1
Total anomalous pulmonary venous return (2), TAPVR1
Spermatogenic failure, X-linked, SPGFX2
Plasminogen deficiency, type I, PLG
?Testicular microlithiasis, SLC34A2
Ectodermal dysplasia/skin fragility syndrome, PKP1
Amyloidosis, renal, LYZ
Biotinidase deficiency, BTD
Metachromatic leukodystrophy, ARSA
?Laryngeal adductor paralysis (2), LAP
Amyloidosis, 3 or more types, APOA1
Gaucher disease, type II, GBA
{Hypertension, essential, susceptibility to, 1}, HYT1
{Malignant mesothelioma, MMS
{Stature QTL 8} (2), STQTL8
Schindler disease, type I, NAGA
[Bone mineral density QTL 3] (2), BMND3
Adrenocorticotropic hormone deficiency, TBX19
Glaucoma 1C, GLC1C
{Parkinson disease 12} (2), PARK12
{Autism susceptibility 1} (2), AUTS1
Orofacial cleft 13 (2), OFC13
{Colonic adenoma recurrence, reduced risk of}, ODC1
CDAGS syndrome (2), CDAGS
Split-hand/foot malformation with long bone deficiency 2 (2), SHFLD2
{Inflammatory bowel disease 20} (2), IBD20
Nanophthalmos-1 (2), NNO1
Hypophosphatemic rickets and hyperparathyroidism (2), HPRHP
{Metabolic syndrome, protection against}, MTP
Orofacial cleft 4 (2), OFC4
{Rheumatoid arthritis, RA
Histiocytoma, angiomatoid fibrous, somatic, CREB1
Glutamate formiminotransferase deficiency, FTCD
{Scoliosis, isolated, susceptibility to, IS3
Vertigo, benign recurrent, BRV2
Neurofibromatosis, type 2, NF2
[Novelty seeking personality], DRD4
{?Allergy and asthma susceptibility} (2), IGES
Weill-Marchesani-like syndrome, ADAMTS17
Renal cell carcinoma, papillary, 1, familial and somatic, MET
Anosmia, ANIC
{Malignant hyperthermia susceptibility 4} (2), MHS4
{Hypospadias 4, X-linked, HYSP4
Obesity, autosomal dominant, MC4R
Dopamine receptor D2, ANKK1
Atrial septal defect 1 (2), ASD1
DNA ligase I deficiency (3), LIG1
Colorectal cancer with chromosomal instability, BUB1
Cavitary optic disc anomalies (2), CODA
[Anhaptoglobinemia], HP
ApoA-I and apoC-III deficiency, APOA1
{Glioma susceptibility 4} (2), GLM4
{Osteoporosis, postmenopausal}, COL1A2
Cholestasis, VIL1
Thalassemia, HBD
Weyers acrodental dysostosis, EVC
[High density lipoprotein cholesterol level QTL 2] (2), HDLCQ2
Epilepsy, childhood absence, ECA1
Vesicoureteral reflux (2), VUR
Arrhythmogenic right ventricular dysplasia 3 (2), ARVD3
Lymphocytic leukemia, RAP1GDS1
{Low renin hypertension, CYP11B2
Emanuel syndrome (4), DER22t11-22
Alopecia-mental retardation syndrome 1 (2), APMR1
[Blood group GIL], AQP3
Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis, SARS2
Isobutyryl-CoA dehydrogenase deficiency, ACAD8
{Inflammatory bowel disease 6} (2), IBD6
[?Hyperproglucagonemia] (1), GCG
{Hypertension, essential, salt-sensitive}, ADD1
Mental retardation, severe, MRST
Stargardt disease 4 (2), STGD4
{Glioma, susceptibility to, somatic}, IDH1
Bare lymphocyte syndrome, type II, complementation group C, RFX5
Bare lymphocyte syndrome, type II, complementation group E, RFX5
Bare lymphocyte syndrome, type II, complementation group D, RFXAP
Thalassemia-beta, dominant inclusion-body, HBB
{Stature QTL 16} (2), STQTL16
{Age-related hearing impairment 1} (2), ARHI1
{Asperger syndrome susceptibility 3} (2), ASPG3
[Blood group, Kell], KEL
Myotonia congenita, recessive, CLCN1
[High density lipoprotein cholesterol level QTL 1] (2), HDLCQ1
[Sex hormone-binding blobulin circulating level QTL 1] (2), SXGQTL1
Hyperchlorhidrosis, isolated, CA12
Dystonia 13, DYT13
Senior-Loken syndrome 3 (2), SLSN3
Ichthyosis, congenital, autosomal recessive 7, ARCI7
Forsythe-Wakeling syndrome (2), FWS
Wegener granulomatosis (2), WG
{Spinal muscular atrophy, type III, modifier of}, SMN2
[Visuospatial/perceptual abilities] (2), VSPA
[Birth weight QTL4] (2), BWQTL4
Pulmonary disease, chronic obstructive, COPD
Hemosiderosis, systemic, due to aceruloplasminemia, CP
Supernumerary der(22)t(8-22) syndrome (4), DER22t8-22
Alpha/beta T-cell lymphopenia with gamma/delta T-cell expansion, severe cytomegalovirus infection, and autoimmunity, RAG1
[Body mass index QTL2] (2), BMIQ2
{Lung cancer susceptibility 5} (2), LNCR5
{Alzheimer disease 12} (2), AD12
Pyridoxamine 5'-phosphate oxidase deficiency, PNPO
[Mean platelet volume QTL3] (2), MPVQTL3
Vesicoureteral reflux 5 (2), VUR5
{Autism susceptibility 3} (2), AUTS3
Canavan disease, ASPA
Epilepsy, X-linked, with variable learning disabilities and behavior disorders, SYN1
?{Amyotrophic lateral sclerosis, susceptibility to}, NEFH
{Vitamin B6 plasma level QTL 1} (2), B6QTL1
Transient erythroblastopenia of childhood (2), TEC
CHILD syndrome, NSDHL
{Leprosy, susceptiblity to, LPRS6
Orofacial cleft 14 (2), OFC14
Transaldolase deficiency, TALDO1
Dermatopathia pigmentosa reticularis, KRT14
Anisomastia (2), ANMA
{Influenza, severe, susceptibility to}, IFITM3
[Bone size quantitative trait locus 3] (2), BSZQTL3
{Sarcoidosis, susceptibility to, SS3
{Lung cancer susceptibility} (2), LNCR1
?Hepatocellular carcinoma (1), LCO
Spinal muscular atrophy, chronic distal, SMAR
Hypospadias 3, HYSP3
Panbronchiolitis, PBLT
{Mental health wellness-2} (2), MHW2
{Diabetes mellitus, IDDM1
Gastrointestinal stromal tumor, somatic, PDGFRA
Dopamine beta-hydroxylase deficiency, DBH
Platelet PLC beta-2 deficiency (1), PLCB2
Ehlers-Danlos syndrome, cardiac valvular form, COL1A2
Robinow syndrome, autosomal dominant 1, WNT5A
Xeroderma pigmentosum, group E, DDB-negative subtype, DDB2
Congenital heart defects, multiple types, CHDT3
{Restless legs syndrome, susceptibility to, RLS8
Ciliary dyskinesia, primary, 14, CCDC39
Ventricular tachycardia, catecholaminergic polymorphic, 2, CASQ2
Male germ cell tumor (2), MGCT
Hypoparathyroidism, autosomal dominant, PTH
Hypoaldosteronism, congenital, due to CMO I deficiency, CYP11B2
Otosclerosis 8 (2), OTSC8
Synpolydactyly 3 (2), SPD3
Aneurysmal bone cysts (2), ANBC
Methylmalonic aciduria, vitamin B12-responsive, due to defect in synthesis of adenosylcobalamin, cblB complementation type, MMAB
Hypotrichosis 9 (2), HYPT9
Bothnia retinal dystrophy, RLBP1
{Alzheimer disease-13} (2), AD13
Muscular dystrophy with rimmed vacuoles (2), MDRV
Ptosis, hereditary congenital, PTOS1
?Retinal cone dystrophy-1 (2), RCD1
Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency, GPI
{Psoriasis susceptibility 6} (2), PSORS6
Hypoparathyroidism, familial isolated, GCMB
Epilepsy, partial, EPPS
Hypodysfibrinogenemia, FGG
Retinoblastoma, RB1
{Cardiac conduction defect, susceptibility to}, AKAP10
Cousin syndrome, TBX15
Glycogen storage disease 0, liver, GYS2
?Preauricular fistulae, PAFC
{Restless legs syndrome 7} (2), RLS7
Amyotrophic lateral sclerosis 7 (2), ALS7
Cayler cardiofacial syndrome (2), ACF
Oculomotor apraxia, congenital, COMA
{Prostate cancer, susceptibility to, 4}, HPC4
Orofacial cleft-2 (2), OFC2
[Sprinting performance] (3), ACTN3
Burkitt lymphoma, MYC
[High density lipoprotein cholesterol level QTL 5] (2), HDLCQ5
{Psoriasis susceptibility 8} (2), PSORS8
Keratoderma, palmoplantar, PPKP1B
Thalassemias, beta-, HBB
Left ventricular noncompaction 2 (2), LVNC2
Panic disorder 3 (2), PAND3
Microcephaly, mental retardation, and distinctive facies, MMRFCGU
Combined C6/C7 deficiency (3), C6
Spondylocheirodysplasia, Ehlers-Danlos syndrome-like, SLC39A13
[Bone mineral density QTL 2] (2), BMND2
Goldberg-Shprintzen megacolon syndrome, KIAA1279
?Antiphospholipid syndrome, ATPLS
Miyoshi muscular dystrophy 2 (2), MMD2
[Fasting plasma glucose level QTL 1] (2), FGQTL1
[Fasting plasma glucose level QTL 4] (2), FGQTL4
Eosinophilia, EOS
[QT interval, QTV
[Urate oxidase deficiency] (1), UOX
HMG-CoA synthase-2 deficiency, HMGCS2
{Glioma susceptibility 6} (2), GLM6
SC phocomelia syndrome, ESCO2
{Inflammatory bowel disease 15} (2), IBD15
{Migraine, familial typical, susceptibility to, MGR2
Mental retardation, X-linked, syndromic, MRXSMP
Cystinosis, late-onset juvenile or adolescent nephropathic, CTNS
Glycine N-methyltransferase deficiency, GNMT
Rickets due to defect in vitamin D 25-hydroxylation, CYP2R1
Photoparoxysmal response 2 (2), PPR2
{Thromboembolism, susceptibility to}, MTHFR
Fucosyltransferase 6 deficiency, FUT6
McArdle disease, PYGM
Optic atrophy 6 (2), OPA6
Factor XI deficiency, autosomal dominant, F11
{Endometriosis, susceptibility to, ENDO1
{Parkinson disease 3} (2), PARK3
Spinocerebellar ataxia 25 (2), SCA25
Keratoconus 2 (2), KTCN2
Panic disorder syndrome 1 (2), PAND1
Hypereosinophilic syndrome, idiopathic, resistant to imatinib, PDGFRA
Microphthalmia with coloboma 2 (2), MCOPCB2
Myasthenia gravis with thymus hyperplasia (2), MYAS1
{Asperger syndrome susceptibility 1} (2), ASPG1
Mammary-digital-nail syndrome (2), MDNS
[Dopamine-beta-hydroxylase activity levels, DBH
Myelodysplasia syndrome-1 (3), MDS1
Xanthinuria, type I, XDH
Fetal hemoglobin quantitative trait locus 4 (2), HBFQTL4
Nystagmus 3, congenital, NYS3
{Inflammatory bowel disease 18} (2), IBD18
Meningioma, NF2-related, somatic, NF2
Growth retardation with deafness and mental retardation due to IGF1 deficiency, IGF1
Phobia, PHOBS
Osteoarthritis with mild chondrodysplasia, COL2A1
[AMP deaminase deficiency, erythrocytic], AMPD3
CD8 deficiency, familial, CD8A
Alzheimer disease-11 (2), AD11
Complex I, mitochondrial respiratory chain, deficiency of, NDUFS6
Dystonia, dopa-responsive, due to sepiapterin reductase deficiency, SPR
{Stature QTL 4} (2), STQTL4
Spinocerebellar ataxia, autosomal recessive with axonal neuropathy, TDP1
Corneal clouding, APOA1
?ACAT2 deficiency, ACAT2
Synesthesia (2), SYNSTH
Friedreich ataxia 2 (2), FRDA2
Retinoblastoma, trilateral, RB1
Exocrine pancreatic insufficiency, dyserythropoietic anemia, and calvarial hyperostosis, COX4I2
Wood neuroimmunologic syndrome (2), INDX
?Hyperimmunoglobulin G1 syndrome (2), IGHR
Cushing syndrome, ACTH-independent adrenal, somatic, PRKACA
Lymphoma/leukemia, B-cell, FVT1
Alopecia-mental retardation syndrome 2 (2), APMR2
Deafness, autosomal recessive 36, ESPN
CPT deficiency, hepatic, type IA, CPT1A
Holt-Oram syndrome, TBX5
Otosclerosis 7 (2), OTSC7
Diphenylhydantoin toxicity (1), EPHX1
{Smoking as a quantitative trait locus 1} (2), SQTL1
Porphyria cutanea tarda, UROD
{Stature QTL 23} (2), STQTL23
Myopia 13 (2), MYP13
Macrothrombocytopenia, autosomal dominant, TUBB1-related, TUBB1
Li-Fraumeni syndrome 3 (2), LFS3
Acromegaloid features, overgrowth, cleft palate, AOCH
Hereditary persistence of fetal hemoglobin, HBB
Myopia 20, MYP20
{Leukemia, acute lymphocytic, susceptibility to, ALL1
Joubert syndrome-3, AHI1
{Ischemic stroke, susceptibility to}, NOS3
Alopecia areata 2 (2), AA2
{Opioid dependence, susceptibility to, ODS1
Alzheimer disease 8, AD8
Alzheimer disease 6, AD6
Episodic muscle weakness, EMWX
Retinitis pigmentosa 24 (2), RP24
Myopia-2 (2), MYP2
{Age-related hearing impairment 2} (2), ARHI2
Cystinosis, nephropathic, CTNS
Trichorhinophalangeal syndrome, type III, TRPS1
Telangiectasia, HBT
{Alzheimer disease-14} (2), AD14
Aural atresia, CAA
Myoglobinuria, acute recurrent, autosomal recessive, LPIN1
Muscle strength quantitative trait locus 1 (2), MUSTQTL1
{Psoriasis susceptibility 3} (2), PSORS3
Cone-rod dystrophy 8 (2), CORD8
{High density lipoprotein cholesterol, low serum, HDLC3
Moyamoya disease 3 (2), MYMY3
Glomerulopathy with fibronectin deposits 1 (2), GFND1
Zygodactyly 1 (2), ZD1
Chromosome 2q31.2 deletion syndrome (4), DEL2q31
Cone-rod dystrophy 17 (2), CORD17
Glaucoma 3, primary congenital, GLC3C
[Hypohaptoglobinemia], HP
Beta-2-adrenoreceptor agonist, ADRB2
Camptodactyly 1 (2), CAMPD1
Bartter syndrome, type 3, CLCNKB
{Atrial fibrillation, familial, ATFB5
Jacobsen syndrome (4), JBS
Spastic paraplegia 19, SPG19
Spastic paraplegia 14, SPG14
Pierre Robin syndrome (2), PRBNS
{Osteoarthritis susceptibility 6} (2), OS6
Nephropathy, progressive, NEDE
Vohwinkel syndrome with ichthyosis, LOR
Otosclerosis 5 (2), OTSC5
{Anorexia nervosa, susceptibility to, ANON1
{Malignant hyperthermia susceptibility 2} (2), MHS2
Vitreoretinopathy with phalangeal epiphyseal dysplasia (3), COL2A1
{Leber optic atrophy, LOAS
Legg-Calve-Perthes disease, COL2A1
Ectodermal dysplasia 5, ECTD5
Ectodermal dysplasia 8, ECTD8
Arthrogryposis, distal, DA10
?Sertoli-cell-only syndrome (1), DAZ
Kyphoscoliosis 1 (2), KYPSC1
Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia, PAX8
{Systemic lupus erthematosus, susceptibility to, SLEB15
Leukoencephalopathy with metaphyseal chondrodysplasia (2), LKMCD
Myopia 18 (2), MYP18
[Erythrocytosis, familial, 1], EPOR
Periodontitis, aggressive, PDON2
?Tibial hemimelia (2), THM
Nystagmus 5, congenital, NYS5
Warfarin sensitivity, CYP2C9
{Systemic lupus erythematosus with hemolytic anemia} (2), SLEH1
{Lewy body dementia, susceptibility to}, GBA
Myopia 11 (2), MYP11
Delta-beta thalassemia, HBB
Nystagmus 4, congenital, NYS4
{Pulmonary function} (2), PLF
Aplasia of lacrimal and salivary glands, FGF10
?Retinitis pigmentosa, X-linked recessive, RP6
Myopia 7 (2), MYP7
{Myocardial infarction, susceptibility to, MCI2
Myopia 19 (2), MYP19
[Fasting plasma glucose level QTL 3] (2), FGQTL3
{Obsessive-compulsive disorder, susceptibility to}, HTR2A
Spastic paraplegia 38, SPG38
Spastic paraplegia 32, SPG32
Spastic paraplegia 37, SPG37
Spastic paraplegia 36, SPG36
Spastic paraplegia 34, SPG34
Radial ray deficiency (2), RRDX
Methylmalonic aciduria and homocystinuria, cblC type, MMACHC
Amyotrophic lateral sclerosis 3 (2), ALS3
Larsen-like syndrome (2), LRSL
Angio serpiginosum (2), AGSPX
Chondrocalcinosis with early-onset osteoarthritis (2), CCAL1
Adenosine deaminase deficiency, partial, ADA
Aldosterone to renin ratio raised (3), CYP11B2
{Stature QTL 5} (2), STQTL5
Sensorineural deafness with mild renal dysfunction, BSND
{Follicular lymphoma, susceptibility to, FL1
Keratoconus 7 (2), KTCN7
{Restless legs syndrome 4} (2), RLS4
Ehlers-Danlos syndrome, type IV, COL3A1
?Zimmermann-Laband syndrome (2), ZLS
{Inflammatory bowel disease 3} (2), IBD3
Saccharopinuria, AASS
{Lung cancer susceptibility 3} (2), LNCR3
{Autism susceptibility 12} (2), AUTS12
Potocki-Lupski syndrome (4), PTLS
Erythrocytosis due to bisphosphoglycerate mutase deficiency, BPGM
Ulnar-mammary syndrome, TBX3
{Psoriasis susceptibility 5} (2), PSORS5
[Glutaric aciduria III], C7orf10
Osteopetrosis, autosomal recessive 3, with renal tubular acidosis, CA2
Pelviureteric junction obstruction (2), PUJO
C6 deficiency, C6
Muscle glycogenosis, PHKA1
?Hairy ears, HEY
Pseudovaginal perineoscrotal hypospadias, SRD5A2
{Psoriasis susceptibility 12} (2), PSORS12
Alcohol sensitivity, acute, ALDH2
Dystonia-7, DYT7
?Thrombophilia due to decreased release of tissue plasminogen (1), THPH9
Alzheimer disease-7 (2), AD7
Otosclerosis 10 (2), OTSC10
{Inflammatory bowel disease 16} (2), IBD16
Microphthalmia with cataract 1 (2), MCOPCT1
Abetalipoproteinemia, MTP
Cleft palate, isolated, UBB
Mental retardation, autosomal recessive 35, MRT35
{Stature QTL 22} (2), STQTL22
?EEC syndrome-1 (2), EEC1
{Tuberculosis, MTBS1
Somatostatin analog, SSTR5
Obesity, adrenal insufficiency, and red hair due to POMC deficiency, POMC
Fructose intolerance, ALDOB
[Skin/hair/eye pigmentation 11, SHEP11
?Paget disease of bone (2), PDB
Sucrase-isomaltase deficiency, congenital, SI
{Vitiligo-associated multiple autoimmune disease susceptiblity 6} (2), VAMAS6
{Asthma, protection against}, MUC7
Ulna and fibula, absence of, with severe limb deficiency, WNT7A
[Hematocrit/hemoglobin quantitative trait locus 2] (2), HCHGQ2
{Intelligence QTL1} (2), INTLQ1
{Stature QTL 18} (2), STQTL18
Chronic granulomatous disease, autosomal, due to deficiency of CYBA, CYBA
?Melkersson-Rosenthal syndrome (2), MROS
[Cinnamon odor, CINN
Ocular albinism with sensorineural deafness (2), OASD
{Inflammatory bowel disease 9} (2), IBD9
{Nevus sebaceous, somatic}, HRAS
Retinitis pigmentosa 32 (2), RP32
?Thrombocytopenia, TCPT
von Hippel-Lindau syndrome, VHL
Wolf-Hirschhorn syndrome (4), WHS
Glycogen storage disease II, GAA
{Asperger syndrome susceptibility 4} (2), ASPG4
X inactivation, familial skewed, SXI2
[Bone mineral density QTL 10] (2), BMND10
[Fasting insulin level quantitative trait locus 1] (2), FIQTL1
Microtia with nasolacrimal duct imperforation and eye coloboma (1), MNDEC
Spastic paraplegia 9, SPG9
{Psoriasis susceptibility 4} (2), PSORS4
MEHMO syndrome (2), MEHMO
[Rh-negative blood type] (3), RHD
Retinitis pigmentosa, RPY
{Autism susceptibility 6} (2), AUTS6
[Telomere length, TELM
Amyotrophic lateral sclerosis 5, ALS5
Charcot-Marie-Tooth disease, CMTDIA
Hyperlipidemia, combined, HYPLIP2
Acatalasemia, CAT
{Inflammatory bowel disease 23} (2), IBD23
{Stature QTL 21} (2), STQTL21
[Musical aptitude QTL 1] (2), MUSQTL1
{Osteoporosis, susceptibility to}, RIL
{Esophageal cancer, alcohol-related, ALDH2
Split-hand/foot malformation 5 (2), SHFM5
Spinocerebellar ataxia 12, PPP2R2B
Hypertensive nephropathy (2), HNP1
Spastic paraplegia, optic atrophy, SPOAN
Arthrogryposis, distal, type 2A, MYH3
{Diabetes, type 2, susceptibility to}, GPD2
DNA topoisomerase I, TOP1
Muscular dystrophy, congenital, due to ITGA7 deficiency, ITGA7
3-beta-hydroxysteroid dehydrogenase, type II, deficiency, HSD3B2
?Coffin-Siris syndrome (2), CSS
Orofacial cleft 9 (2), OFC9
{Leukemia, acute lymphoblastic, susceptibility to, ALL2
?Osteoporosis, involutional, VDR
Cystinosis, ocular nonnephropathic, CTNS
Cataract 29, CTRCT29
Schindler disease, type III, NAGA
Neurodegeneration due to cerebral folate transport deficiency, FOLR1
Isovaleric acidemia, IVD
{Human herpesvirus 8, HHV8S
Gallbladder disease 3 (2), GBD3
3-hydroxyisobutryl-CoA hydrolase deficiency, HIBCH
C7 deficiency, C7
C8 deficiency, type I, C8A
Hyperuricemic nephropathy, familial juvenile, HNFJ3
{Ovarian cancer, OVCAS1
Epidermolysis bullosa, junctional, with pyloric atresia, ITGB4
Narcolepsy 2 (2), NRCLP2
Periventricular nodular heterotopia 5 (4), PVNH5
Preeclampsia/eclampsia 2 (2), PEE2
{Hypertension, essential, susceptibility to, 6}, HYT6
Fuhrmann syndrome, WNT7A
Arrhythmogenic right ventricular dysplasia 4 (2), ARVD4
Testicular germ cell tumor (2), TGCT1
Renal cell carcinoma, somatic, VHL
Trichorhinophalangeal syndrome, type I, TRPS1
Eosinophil peroxidase deficiency, EPX
{Lumbar disc disease, susceptibility to}, CILP
Kniest dysplasia, COL2A1
Kondoh syndrome (2), KONDS
Orofacial cleft 12 (2), OFC12
Cerebral palsy, ataxic, ACP
6-mercaptopurine sensitivity, TPMT
Hyperparathyroidism 3 (2), HRPT3
{Prostate cancer aggressiveness QTL}, HPCQTL19
Megaloblastic anemia-1, Norwegian type, AMN
Hypoaldosteronism, congenital, due to CMO II deficiency, CYP11B2
[Body mass index QTL3] (2), BMIQ3
Insulinoma (1), ITS
Fabry disease, GLA
3-methylglutaconic aciduria, type I, AUH
Prolidase deficiency, PEPD
Alpha-methylacetoacetic aciduria, ACAT1
Aromatic L-amino acid decarboxylase deficiency, DDC
{Major affective disorder 5} (2), MAFD5
Endometrial carcinoma, MSH3
Spinocerebellar ataxia 37 (2), SCA37
[Mean platelet volume QTL2] (2), MPVQTL2
Factor XIIIB deficiency, F13B
Developmental dysplasia of the hip 2 (2), DDH2
?Myosclerosis, congenital, COL6A2
Hair, HRM2
[Blood group, ABO system], ABO
Leukemia, Philadelphia chromosome-positive, ABL1
Neuropathy, hereditary sensory, HSN1B
Galactosemia, GALT
Dyskeratosis, DKBI
Acne inversa, familial, 1, NCSTN
Aspartylglucosaminuria, AGA
{Psoriasis susceptibility 7} (2), PSORS7
Exudative vitreoretinopathy 3 (2), EVR3
Usher syndrome, type IIC, GPR98/PDZD7 digenic, PDZD7
Porphyria, hepatoerythropoietic, UROD
{Hypertension, essential, susceptibility to, 4}, HYT4
{Leprosy, paucibacillary type, LPRS
{Aneurysm, AAA3
Keratoconus 8 (2), KTCN8
Episodic kinesigenic dyskinesia 2 (2), EKD2
Brunner syndrome, MAOA
?Roifman-Chitayat syndrome (2), RCHTS
{Obesity, early-onset, susceptibility to}, POMC
Hyperlipoproteinemia, type Ib, APOC2
SED congenita, COL2A1
Cutis laxa, AD, ELN
Hyperinsulinism-hyperammonemia syndrome, GLUD1
Hepatocellular carcinoma, childhood type, MET
Hyperbiliverdinemia, BLVRA
{Autism susceptibility 5} (2), AUTS5
Roifman syndrome (2), RFMN
Leukemia, acute lymphoblastic, somatic, FLT3
{Stature QTL 9} (2), STQTL9
Gaucher disease, type I, GBA
Leukemia-2, TAL2
Cerebral-cerebellar-coloboma syndrome, CCCSX
{Pulmonary hypertension, chronic thromboembolic, without deep vein thrombosis, CTEPH1
{Obesity, severe, and type II diabetes}, UCP3
{Mycobacerium tuberculosis, susceptibility, MTBSX
Newfoundland rod-cone dystrophy, RLBP1
Deafness, neurosensory, without vestibular involvement, ESPN
Porphyria variegata, PPOX
{Inflammatory bowel disease 7} (2), IBD7
?Lysosomal acid phosphatase deficiency, ACP2
Pallister-Killian syndrome (4), PKS
{Malignant hyperthermia susceptibility 6} (2), MHS6
[Bone mineral density QTL 11] (2), BMND11
{Hypertension, essential, susceptibility to, 2}, HYT2
{Hypertension, pregnancy-induced}, NOS3
[Body mass index QTL13] (2), BMIQ13
{Placental abruption} (3), NOS3
Lipoma, MEN1
{Restless legs syndrome 6} (2), RLS6
Glycogen storage disease VI, PYGL
Hemolytic anemia due to adenylate kinase deficiency, AK1
T-cell acute lymphoblastic leukemia, somatic, BAX
Occult macular dystrophy, RP1L1
Myopia 5 (2), MYP5
Fucosidosis, FUCA1
Hematuria, COL4A4
Platyspondylic skeletal dysplasia, Torrance type, COL2A1
Angiofibroma, MEN1
Photoparoxysmal response 1 (2), PPR1
{Stature QTL 6} (2), STQTL6
Glutaricaciduria, type I, GCDH
Myoclonic epilepsy, juvenile, EJM4
{Prostate cancer, susceptibility to, 3}, HPC3
Bartter syndrome, type 4a, BSND
FG syndrome 3 (2), FGS3
Spastic paraplegia 16, X-linked, SPG16
Corneal dystrophy, endothelial, XECD
Hyperaldosteronism, familial, FHII
Infections, recurrent, with encephalopathy, hepatic dysfunction, and cardiovasuclar malformations, FADD
{Alzheimer disease-15} (2), AD15
Porokeratosis 7 (2), POROK7
Mitochondrial complex II deficiency, SDHAF1
Myopia 10 (2), MYP10
Ventricular tachycardia, catecholaminergic polymorphic, CPVT3
{Hepatic fibrosis susceptibility due to Schistosoma mansoni infection} (2), SM2
Sebaceous tumors, LEF1
Stickler syndrome, type I, COL2A1
[Polyunsaturated fatty acids plasma level QTL1] (2), PURAQTL1
[Hematocrit/hemoglobin quantitative trait locus 1] (2), HCHGQ1
Vesicoureteral reflux 6 (2), VUR6
{Alzheimer disease 16} (2), AD16
Lipoma (3), LPP
Adenylosuccinase deficiency, ADSL
Polycystic kidney disease, infantile severe, PKDTS
{Smoking as a quantitative trait locus 2} (2), SQTL2
?Progesterone resistance, PGR
{Inflammatory bowel disease 27} (2), IBD27
Spondyloperipheral dysplasia, COL2A1
Polycystic kidney disease 2, PKD2
Postaxial polydactyly, PAPA2
?Ragweed sensitivity (2), RWS
[Gamma-glutamyltransferase, GGT2
?Stomatocytosis I, EPB72
{Hypertension, diastolic, resistance to}, KCNMB1
Pigmented nodular adrenocortical disease, primary, PPNAD4
Orofacial cleft-3 (2), OFC3
Glycerol kinase deficiency, GK
{Autism susceptibility 13} (2), AUTS13
[Fetal hemoglobin QTL5] (2), HBFQTL5
Hirschsprung disease, cardiac defects, and autonomic dysfunction, ECE1
Mean platelet volume QTL6 (2), MPVQTL6
{Otitis media, OMS
{Rheumatoid arthritis, systemic juvenile, susceptibility to}, MIF
Keutel syndrome, MGP
HMG-CoA lyase deficiency, HMGCL
Troyer syndrome, SPG20
Tukel syndrome (2), TUKLS
Abdominal obesity-metabolic syndrome (2), AOMS2
Otosclerosis 3 (2), OTSC3
{Inflammatory bowel disease 5} (2), IBD5
{Hypersensitivity syndrome, carbamazepine-induced, susceptibility to}, HLA-A
Multiple endocrine neoplasia 1, MEN1
[Ezetimibe, NPC1L1
MASP2 deficiency, MASP2
Hyperchylomicronemia, late-onset, APOA5
{Hangover, susceptibility to}, ALDH2
Pycnodysostosis, CTSK
Welander distal myopathy (2), WDM
[High density lipoprotein cholesterol level QTL 4] (2), HDLCQ4
{Coronary artery spasm 1, NOS3
Gallbladder disease 2 (2), GBD2
Cholangitis, PSC
Acute insulin response (2), AIR
Lymphedema, hereditary, LMPH1B
Mean platelet volume QTL4 (2), MPVQTL4
Brooks-Wisniewski-Brown syndrome (2), MRXSBWB
Orthostatic hypotensive disorder of Streeten (2), OHDS
Leukoencephalopathy with dystonia and motor neuropathy, SCP2
Keratoconus 6 (2), KTCN6
{Cancer progression/metastasis} (3), FGFR4
[Superoxide dismutase, SOD3
Macrostomia (2), MACST
{Parkinson disease 16} (2), PARK16
Hawkinsinuria, HPD
Gaucher disease, perinatal lethal, GBA
Vesicoureteral reflux 4 (2), VUR4
Neutrophil immunodeficiency syndrome, RAC2
Macular dystrophy, retinal, MCDR3
Ceroid lipofuscinosis, neuronal, 5, CLN5
Tyrosinemia, type III, HPD
Factor VII deficiency, F7
[Body mass index QTL6] (2), BMIQ6
Gaucher disease, type IIIC, GBA
Dyschromatosis universalis hereditaria 2 (2), DUH2
Carcinoid tumor of lung (3), MEN1
Bardet-Biedl syndrome 5, BBS5
Bardet-Biedl syndrome 7, BBS7
Bardet-Biedl syndrome 1, BBS1
Bardet-Biedl syndrome 2, BBS2
Turner syndrome-associated neurocognitive phenotype (2), VSPA
{Kawasaki disease, susceptibility to}, ITPKC
Gaucher disease, type III, GBA
{Hypertriglyceridemia, HTGS
Immunoglobulin A deficiency (2), IGAD1
{Glioma susceptibility 5} (2), GLM5
Levy-Shanske syndrome (4), LVSKS
Homocysteine plasma level (2), NNMT
Myeloperoxidase deficiency, MPO
Thrombosis, hyperhomocysteinemic, CBS
{Inflammatory bowel disease 12} (2), IBD12
Spinocerebellar ataxia 32 (2), SCA32
Breast cancer (1), BCPR
{Psoraisis susceptibility 9} (2), PSORS9
Exostoses, multiple, EXT3
Microphthalmia with coloboma 1 (2), MCOPCB1
{Asperger syndrome susceptibility 2} (2), ASPG2
[Body mass index QTL 15] (2), BMIQ15
[Lean body mass QTL 1] (2), LBMQTL1
{Stature QTL 15} (2), STQTL15
[Respiratory rhythmicity in sleep] (2), RRIS
Medulloblastoma, PTCH2
Dystonia, myoclonic, DRD2
{Autism susceptibility 11} (2), AUTS11
Homocystinuria due to MTHFR deficiency, MTHFR
Ectodermal dysplasia-syndactyly syndrome 2 (2), EDSS2
Combined malonic and methylmalonic aciduria, ACSF3
{Autism susceptibility 8} (2), AUTS8
Stickler sydrome, type I, nonsyndromic ocular, COL2A1
Holoprosencephaly-8 (2), HPE8
[Bone mineral density QTL 4] (2), BMND4
?Heterotaxy, visceral, 3, HTX3
{Inflammatory bowel disease 22} (2), IBD22
Glaucoma 1D, GLC1D
Retinitis pigmentosa 2, RP2
Mucolipidosis III gamma, GNPTAG
{Gilles de la Tourette syndrome, susceptibility to}, HDC
OKT4 epitope deficiency, CD4
Hyperphenylalaninemia, BH4-deficient, A, PTS
Alpha-ketoglutarate dehydrogenase deficiency, OGDH
{Drug addiction, susceptibility to}, FAAH
Carnosinemia (2), CNSN
[Blood group, OK], BSG
{Stature QTL 20} (2), STQTL20
?Mental retardation, X-linked, MRXS12
Branchiootic syndrome 2 (2), BOS2
{Epilepsy, idiopathic generalized, EIG4
Ornithine transcarbamylase deficiency, OTC
{Coronary heart disease, CHDS1
Ehlers-Danlos syndrome, EDS8
?Spinocerebellar ataxia 30 (2), SCA30
Kanzaki disease, NAGA
{Schizophrenia 10} (2), SCZD10
Epidermolysis bullosa, junctional, with pyloric stenosis, ITGA6
{Patent ductus arteriosus, PDA1
[C-reactive protein QTL] (2), CPROTQ
Congenital myopathy with excess of muscle spindles, HRAS
[Handedness] (2), HSR
Chromosome 18q deletion syndrome (4), DEL18q
Retinitis pigmentosa 54, C2orf71
Hematuria, benign familial, COL4A3
{Narcolepsy 5} (2), NRCLP5
{Glioma susceptibility 7} (2), GLM7
Fish-eye disease, LCAT
Trichilemmal cyst 1 (2), TRICY1
?Diabetes mellitus, insulin-dependent, PBCA
Optic atrophy 5 (2), OPA5
?Craniofacioskeletal syndrome (2), CFSS
Achondrogenesis, type II or hypochondrogenesis, COL2A1
Myopia-1 (2), MYP1
Periventricular nodular heterotopia 3 (2), PVNH3
{Chordoma, CHDM
Small-cell cancer of lung (2), SCLC1
Spinocerebellar ataxia 4 (2), SCA4
?Leigh syndrome, NDUFA10
Pigment disorder, PDR
Exostoses, multiple, type 2, EXT2
Exostoses, multiple, type 1, EXT1
{Alzheimer disease 9, late onset, susceptibility to}, AD9
Avascular necrosis of the femoral head, COL2A1
Heinz body anemias, beta-, HBB
Spastic paraplegia 23 (2), SPG23
Majeed syndrome, LPIN2
{Prostate cancer, hereditary, 5}, HPC5
Pulmonary alveolar microlithiasis, SLC34A2
Leukoencephaly with vanishing white matter, EIF2B4
[Tuberculin skin test reactivity QTL] (2), TST2
{Inflammatory bowel disease 4} (2), IBD4
Tetrasomy 18p (4), TET18P
Anemia, hypochromic microcytic, NRAMP2
Muscular dystrophy, limb-girdle, LGMD1H
Alopecia-mental retardation syndrome 3 (2), APMR3
Tyrosinemia, type I, FAH
Severe combined immunodeficiency due to IL2 deficiency (1), IL2
[Blood group, Rhesus], RHCE
Neuronopathy, distal hereditary motor, DHMN1
[LPA deficiency, LPA
SMED Strudwick type, COL2A1
Preauricular tag, isolated, autosomal dominant, PAURT1
Temple syndrome (4), TEMPS
Thyrotropin-releasing hormone resistance, TRHR
Gastroesophageal reflux (2), GER
Leukemia, acute myeloid, reduced survival in, FLT3
Myopia 8 (2), MYP8
Nystagmus 7, congenital, NYS7
Mungan syndrome (2), MGS
Macrocephaly with multiple epiphyseal dysplasia and distinctive facies (2), MMEDF
[Inosine triphosphatase deficiency], ITPA
Disordered steroidogenesis due to cytochrome P450 oxidoreductase, POR
Homocystinuria, B6-responsive and nonresponsive types, CBS
Dyserythropoietic anemia, congenital, type Ib, C15orf41
Anemia, sideroblastic, pyridoxine-refractory, autosomal recessive, SLC25A38
Macular dystrophy, butterfly-shaped pigmentary, MDBS2
Fabry disease, cardiac variant, GLA
Meier-Gorlin syndrome 4, CDT1
Hemifacial microsomia (2), HFM
Thalassemia due to Hb Lepore (3), HBD
{Speech-sound disorder} (2), SSD
{Stature QTL 7} (2), STQTL7
Acropectorovertebral dysplasia (2), ACRPV
Ehlers-Danlos syndrome, type III, COL3A1
Cubitus valgus with mental retardation and unusual facies (2), CVMRF
Bazex syndrome (2), BZX
[Social cognition] (2), CGF1
{Restless legs syndrome 2} (2), RLS2
C8 deficiency, type II, C8B
Cystathioninuria, CTH
Mental retardation syndrome, X-linked, MRXSA
{Schistosoma mansoni infection, SM1
Radiation sensitivity/chromosome instability syndrome, RSCIS
Photoparoxysmal response 3 (2), PPR3
Methylmalonyl-CoA epimerase deficiency, MCEE
Factor X deficiency, F10
Spiegler-Brooke syndrome (2), SBS
Bernard-Soulier syndrome, type C, GP9
Alopecia areata 1 (2), AA1
Amyloidosis, familial visceral, FGA
[Bone mineral density QTL 6] (2), BMND6
Chromosome 22q11.2 microduplication syndrome (4), DUP22q11.2
Retinitis pigmentosa 22 (2), RP22
Arrhythmogenic right ventricular dysplasia 6 (2), ARVD6
Leigh syndrome due to mitochondrial COX4 deficiency, COX10
Renal cell carcinoma, clear cell, somatic, OGG1
?Anal canal carcinoma (2), ANC
{Malaria, PFBI
[Bone mineral density QTL 14] (2), BMND14
Glaucoma 1B, primary open angle, adult onset, GLC1B
Polycystic kidney disease, adult type I, PKD1
Dupuytren contracture 1 (2), DUPC1
Czech dysplasia, COL2A1
Cardiomyopathy, familial restrictive, RCM2
Hemolytic anemia due to phosphofructokinase deficiency (1), PFKL
?Hypertrichosis universalis congenita, HTC1
{?Hearing loss, cisplatin-induced, CIHL
Chronic granulomatous disease due to deficiency of NCF-1, NCF1
Small patella syndrome, TBX4
{Nasopharyngeal carcinoma, susceptibility to, NPCA2
IgG2 deficiency, IGHG2
Microcephaly 1, primary, autosomal recessive, MCPH1
{Sublingual nitroglycerin, ALDH2
{Podoconiosis, PDCOS
[Mean platelet volume QTL1] (2), MPVQTL1
C1r/C1s deficiency, combined, C1R
Hemangioblastoma, cerebellar, VHL
Galactose epimerase deficiency, GALE
Naegeli-Franceschetti-Jadassohn syndrome, KRT14
Thrombocythemia, THCYTX
[Bone mineral density QTL 9] (2), BMND9
Keratoconus 5 (2), KTCN5
Growth retardation, developmental delay, coarse facies, and early death, FTO
Deafness, autosomal recessive 25, GRXCR1
{Mental health wellness-1} (2), MHW1
Holoprosencephaly-6 (2), HPE6
{Glioma susceptibility 8} (2), GLM8
?Hydrocephalus, HDCPH1
{Preeclampsia, susceptibility to}, EPHX1
{Thyroid carcinoma, follicular, somatic}, HRAS
Epilepsy, nocturnal frontal lobe, ENFL2
Hypotrichosis 10 (2), HYPT10
Hermansky-Pudlak syndrome 4, HPS4
Cystinosis, atypical nephropathic, CTNS
Hermansky-Pudlak syndrome 3, HPS3
Potocki-Shaffer syndrome (4), PSS
[Fructosuria], KHK
Leigh syndrome, due to COX deficiency, SURF1
Epilepsy, rolandic, EPRPDC
Preeclampsia/eclampsia 3 (2), PEE3
Synpolydactyly, 3/3'4, associated with metacarpal and metatarsal synostoses, FBLN1
Dowling-Degos disease 3 (2), DDD3
Epilespy, generalized, with febrile seizures plus, GEFSP8
Albinism, oculocutaneous, OCA5
Hypodysfibrinogenemia, congenital, FGA
{Inflammatory bowel disease 24} (2), IBD24
{Nonsmall cell lung cancer} (2), TSG11
Esophageal carcinoma, somatic, RNF6
Retinitis pigmentosa 63 (2), RP63
Leigh syndrome due to mitochondrial complex 1 deficiency, NDUFA12
Major depressive disorder 1, MDD1
Major depressive disorder 2, MDD2
Paroxysmal nonkinesigenic dyskinesia 2 (2), PNKD2
[Body mass index QTL1] (2), BMIQ1
Costello syndrome, HRAS
Dystonia-17, DYT17
Dystonia-15, DYT15
?Phosphoenolpyruvate carboxykinase-1, cytosolic, deficiency, PCK1
{Vascular disease, MTHFR
Tolbutamide poor metabolizer (3), CYP2C9
[Bone mineral density QTL 13] (2), BMND13
Keratoconus 3 (2), KTCN3
Brugada syndrome 4, CACNB2
{Hodgkin disease susceptibility, HDPA
Microhydranencephaly (2), MHAC
?Male infertility due to acrosin deficiency (2), ACR
{Beryllium disease, chronic, HLA-DPB1
[IgE, elevated level of], IL21R
Fanconi anemia, complementation group F, FANCF
Hypercalciuria, HCA1
SED, COL2A1
Cerebellar ataxia, CP
{Restless legs syndrome 3} (2), RLS3
Keratoconus 4 (2), KTCN4
Creatinine clearance QTL (2), CRCL
Myopia 16 (2), MYP16
{Bladder cancer, somatic}, HRAS
{Retinal disease in Usher syndrome type IIA, modifier of}, PDZD7
Hemorrhagic destruction of the brain, subependymal calcification, and cataracts, JAM3
{Restless legs syndrome 1} (2), RLS1
Alzheimer disease-10, AD10
{Stature QTL 17} (2), STQTL17
Porphyria, congenital erythropoietic, UROS
Hyperlysinemia, AASS
Hypoproteinemia, hypercatabolic, B2M
Arthrogryposis, renal dysfunction, and cholestasis 1, VPS33B
Alzheimer disease-5, AD5
Nanophthalmos 3 (2), NNO3
Glucocorticoid deficiency, due to ACTH unresponsiveness, MC2R
{Prostate cancer, progression of}, HIP1
Retinitis pigmentosa 34 (2), RP34
Dysplasminogenemia, PLG
{Asthma, nocturnal, susceptibility to}, ADRB2
Roberts syndrome, ESCO2
Schwannomatosis, NF2
Hermansky-Pudlak syndrome 1, HPS1
?Spastic paraplegia 41, SPG41
Lacticacidemia due to PDX1 deficiency, PDX1
Trehalase deficiency, TREH
Vestibulopathy, BPPV
{Meconium ileus in cystic fibrosis, CFM1
Growth hormone insensitivity with immunodeficiency, STAT5B
GM2-gangliosidosis, AB variant, GM2A
{Inflammatory bowel disease 8} (2), IBD8
Chondrosarcoma, EXT1
Spastic paraplegia 24, SPG24
Spastic paraplegia 25, SPG25
Spastic paraplegia 26, SPG26
Spastic paraplegia 27, SPG27
Myopia 12 (2), MYP12
Spastic paraplegia 29, SPG29
{Hypercholesterolemia, familial, due to LDLR defect, modifier of}, EPHX2
{Plasmodium falciparum fever episodes QTL1} (2), PFFE1
{Major depressive disorder, response to citalopram therapy in}, HTR2A
Griscelli syndrome, type 3, MLPH
Supravalvar aortic stenosis, ELN
{Malignant hyperthermia susceptibility 3} (2), MHS3
Homocystinuria-megaloblastic anemia, cbl E type, MTRR
{Inflammatory bowel disease 21} (2), IBD21
{Specific language impairment 4} (2), SLI4
Sickle cell anemia, HBB
Hypermethioninemia due to adenosine kinase deficiency, ADK
Coproporphyria, CPOX
Parasomnia, PSMNSW
Glycosylphosphatidylinositol deficiency, PIGM
{Autism susceptibility 4} (2), AUTS4
Adrenal adenoma, MEN1
Thyrotropin-releasing hormone deficiency, TRH
Chromosome 8p11 myeloproliferative syndrome (4), SCLL
{Diabetes mellitus, type 2, susceptiblity to}, MTNR1B
Methylmalonic aciduria, vitamin B12-responsive, MMAA
Bardet-Biedl syndrome 4, BBS4
RIDDLE syndrome, RNF168
?Neuroblastoma (1), TP73
Rajab syndrome (2), RJBS
CK syndrome, NSDHL
Pseudohyperkalemia, familial, 2, PSHK2
{Stature QTL 12} (2), STQTL12
MHC class II deficiency, complementation group B, RFXANK
Hereditary motor and sensory neuropathy V (2), HMSN5
{Stature QTL 14} (2), STQTL14
Hyperhidrosis palmaris et plantaris (2), HHPP
Peripheral arterial occlusive disease 1 (2), PAOD1
Lactase persistence/nonpersistence, MCM6
Aicardi syndrome (2), AIC
Retinitis pigmentosa 29 (2), RP29
Thalassemia, Hispanic gamma-delta-beta, LCRB
Renal hypodysplasia, nonsyndromic, RHDNS1
Myopia 14 (2), MYP14
{Chronic mountain sickness, CMTS
{Stature QTL 24} (2), STQTL24
Hypertension with brachydactyly (2), HTNB
{?Schizophrenia}, SCZD2
Krabbe disease, GALC
[Birth weight QTL 2] (2), BWQTL2
Epiphyseal dysplasia, multiple, with myopia and deafness, COL2A1
{Stature QTL 11} (2), STQTL11
Choroidal dystrophy, CACD1
{Ovarian cancer, somatic}, OPCML
?Fetal hydantoin syndrome (1), EPHX1
Pyruvate carboxylase deficiency, PC
Narcolepsy 3 (2), NRCLP3
{Deafness, nonsyndromic, DFNM1
?N syndrome, POLA1
Alzheimer disease 17 (2), AD17
Diamond-Blackfan anemia 2 (2), DBA2
Mental retardation, X-linked, syndromic, Chudley-Schwartz type, MRXSCS
Factor XI deficiency, autosomal recessive, F11
Deafness, neurosensory, DFNB47
Immunodeficiency, primary, autosomal recessive, IL21R-related, IL21R
Glaucoma 3, primary infantile, GLC3B
[Alpha-actinin-3 deficiency] (3), ACTN3
{?Membranous nephropathy, MBNP
C1s deficiency, C1S
{Bulimia nervosa, BULN
Reticular dysgenesis, AK2
Panic disorder 2 (2), PAND2
{Myocardial infarction, decreased susceptibility to}, F7
Deafness, cataract, retinitis pigmentosa, DFCTRPS
[Hypoceruloplasminemia, hereditary], CP
{Narcolepsy 4} (2), NRCLP4
Myopathy, MPD3
Otosclerosis 2 (2), OTSC2
{Major affective disorder-9, MAFD9
{Major affective disorder-8, MAFD8
Alport syndrome, autosomal dominant, COL4A3
Neurofibrosarcoma (3), MXI1
Rh-null disease, RHCE
Phosphorylase kinase deficiency of liver and muscle, autosomal recessive, PHKB
Myopia 15 (2), MYP15
{Schizophrenia 12}, SCZD12
[Body mass index QTL14] (2), BMIQ14
[Tuberculin skin test reactivity, TST1
Carney complex, CNC2
Autonomic nervous system dysfunction (3), DRD4
{Inflammatory bowel disease 2} (2), IBD2
Syncope, VVS
[Creatine kinase, brain type, CKBE
Megaloblastic anemia due to dihydrofolate reductase deficiency, DHFR
{Lung cancer, protection against, MPO
Tourette syndrome (2), GTS
Chronic granulomatous disease due to deficiency of NCF-2, NCF2
?Keratoderma, palmoplantar, PPKP3
Dystonia 21 (2), DYT21
Dermoids of cornea (2), CND
Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis, POR
Basal ganglia calcification, idiopathic, IBGC2
{Asthma, diminished response to antileukotriene treatment in}, ALOX5
Cone dystrophy, progressive X-linked, COD2
[Hematocrit/hemoglobin quantitative trait locus 3] (2), HCHGQ3
Forebrain defects (3), TDGF1
{Stature QTL 3} (2), STQTL3
{Stature QTL 10} (2), STQTL10
Lipoid adrenal hyperplasia, STAR
Keratolytic winter erythema (2), KWE
Sulfite oxidase deficiency, SUOX
{Migraine, susceptibility to, MGR8
Hypertelorism, preauricular sinus, punctal pits, HPPD
{Lung cancer susceptibility 4} (2), LNCR4
Tyrosinemia, type II, TAT
Leukotriene C4 synthase deficiency, LTC4S
{Psoriasis susceptibility 10} (2), PSORS10
Hypoalphalipoproteinemia, APOA1
Narcolepsy 6 (2), NRCLP6
Cardiomyopathy, hypertrophic, CMH21
Myotonia levior, CLCN1
Vesicoureteral reflux 7 (2), VUR7
[Longevity 2] (2), LGV2
Fructose-1,6-bisphosphatase deficiency, FBP1
{Autism susceptibility 7} (2), AUTS7
[Body mass index QTL5] (2), BMIQ5
Epilepsy, nocturnal frontal lobe, type 4, CHRNA2
Aortic aneurysm, familial abdominal, AAA4
{Epilepsy, juvenile myoclonic, susceptiblity to, EJM9
Ectodermal dysplasia 6, ECTD6
{Restless legs syndrome 5} (2), RLS5
Homocysteine, total plasma, CTH
Mitochondrial complex I deficiency due to ACAD9 deficiency, ACAD9
[Cholesterol level QTL 2] (2), CLQTL2
{Hypertension, essential, susceptibility to, 5}, HYT5
{Stature QTL 19} (2), STQTL19
